| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 706.60 | 26.5% |
| Total Income | 706.60 | 26.5% |
| Expenditure | 565.10 | 27.0% |
| PBT | 147.59 | 24.9% |
| Net Profit | 123.87 | 8.1% |
| OPM | 20.03% | 0.30pp |
| NPM | 17.53% | 2.99pp |
| EPS | 4.35 | 15.4% |
Medpace Reports First Quarter 2026 Revenue of $706.6 million, Up 26.5% YoY
23 Apr 2026 · 23 Apr, 1:45 am
Summary
Medpace Holdings, Inc. announced financial results for the first quarter ended March 31, 2026. Revenue increased by 26.5% to $706.6 million compared to the prior-year period. GAAP net income for the quarter was $123.9 million, or $4.28 per diluted share. The company's EBITDA increased by 25.9% to $149.4 million. The company forecasts full-year 2026 revenue between $2.755 billion and $2.855 billion.
Key Highlights
- 1
Medpace Holdings reported first quarter 2026 revenue of $706.6 million, an increase of 26.5% compared to the prior year.
- 2
Net new business awards for the first quarter of 2026 were $618.4 million, up 23.7% year-over-year.
- 3
GAAP net income for the first quarter of 2026 was $123.9 million, or $4.28 per diluted share.
- 4
EBITDA for the first quarter of 2026 increased 25.9% to $149.4 million.
- 5
Backlog as of March 31, 2026, increased 2.9% to $2,929.2 million from $2,846.0 million as of March 31, 2025.
- 6
The company forecasts 2026 revenue in the range of $2.755 billion to $2.855 billion, representing growth of 8.9% to 12.8% over 2025 revenue.
Informational and educational content only. Not investment advice.